DNA

#3004
Ginkgo Bioworks Holdings, Inc.
7.6300 USD
+14.91%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
7.5329
7.6900
Intervallo Annuale
5.3700
9.7200
Variazione giornaliera
+14.91%
Variazione Mensile
+9.00%
Variazione di 6 mesi
-14.08%
Variazione Annuale
-14.08%
Chiusura Precedente
6.6400
Apertura
7.5329
Bid
Ask
Minimo
7.5329
High
7.6900
Volume
276
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 449.5928 M
  • Employee 485
  • Founded 2008
  • CEO Jason Kelly
  • Website www.ginkgobioworks.com
  • Headquarter Delaware, United States
  • FIGI BBG00YPS1KY3
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.47
Rapporto prezzo/fatturato
2.71

Ginkgo Bioworks Holdings Inc Class A

Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.

Notizie